One Health reports strong growth and revenue boost

One Health Group, based in Sheffield and a provider of surgical services for the NHS, has reported impressive results for the first half of the financial year, marking a significant improvement compared to the previous year.

Revenue for the six months leading up to 30 September 2024 reached £13.4 million, showing an increase of over 20 per cent from the £11.1 million recorded in the same period in 2023. This growth not only surpassed expectations but was fuelled by a 29 per cent rise in new patient numbers, along with the addition of new NHS surgeons to the group and an expansion in surgical capacity. The company anticipates further positive effects on its annual revenue due to a recent settlement in the NHS junior doctors’ pay dispute, which has brought about an increase in the NHS tariff.

The company also expects its full-year underlying EBITDA to surpass the previous expectations of £1.9 million. Progress on plans to develop One Health surgical hubs has been encouraging, and following a positive reception to an initial consultation, a full planning application will be submitted in the upcoming month. The new surgical hub is projected to become operational about a year after construction begins.

Adam Binns, Chief Executive of One Health Group, commented on the recent achievements, noting that the period had brought another phase of strong growth, with the company performing above last year’s levels across key metrics. He attributed this success to the increasing number of NHS patients choosing One Health through the ‘Patient Choice’ programme, along with a growing roster of NHS surgeons now partnering with the group. He also pointed out that the recent shift in Government priorities, highlighting the role of independent sector support in tackling NHS waiting lists, has had a favourable impact on One Health’s business. According to Binns, the company’s approach delivers high-quality surgical care that remains local and free at the point of use, thereby playing an important part in easing pressure on NHS waiting lists.

One Health Group continues to be optimistic about the future, benefiting from a wider recognition of its contribution to NHS patient care and a rising awareness of ‘Patient Choice’ within the public.

One Health Group PLC (AQSE:OHGR) are a team of Consultant Surgeons and Healthcare managers working with the NHS to provide faster, local and expert care in Orthopaedics, Spinal, General Surgery and Gynaecology.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
One Health Group plc

More articles like this

One Health Group plc

NHS expands hubs and private care to cut waiting lists

The UK government is ramping up efforts to tackle England’s extensive NHS waiting lists, currently affecting 7.5 million patients. The Prime Minister has announced plans to expand community diagnostic centres, increase surgical hubs, and enhance private

One Health Group plc

One Health Group to publish Half Year Results during December

One Health Group plc (AQSE: OHGR), an independent provider of free, high quality NHS care for patients referred through ‘Patient Choice’ for treatment in orthopaedics, spine, general surgery and gynaecology, will announce its Half Year Results for

One Health Group plc

Gynaecology care delays highlight urgent need for reform

Gynaecology waiting lists in the UK have more than doubled since early 2020, with current figures indicating over 755,000 pending appointments compared to 360,400 pre-pandemic. This backlog means at least 630,000 people are waiting for care,

One Health Group plc

NHS faces mounting challenges as pressures increase

Recent figures highlight significant challenges for the NHS in England, with performance indicators falling short across emergency services and routine care. Emergency departments saw nearly 50,000 patients wait over 12 hours from the decision to admit

One Health Group plc

NHS waiting lists worsen amidst multiple challenges

NHS waiting lists have escalated significantly in the UK, leaving millions of patients facing extended delays for critical medical treatments. Funding shortfalls are a primary factor behind these delays. Despite increased investment, financial strain continues to